Uncategorized‘We’re targeting the biggest causes of age-related morbidity and mortality’ Empower Meds / November 26, 2025
UncategorizedLongevity.Technology launches consumer products division Empower Meds / November 26, 2025
UncategorizedMetsera lands £215m to accelerate obesity and metabolic disease pipeline Empower Meds / November 26, 2025
Uncategorized65% of longevity clinicians think Bryan Johnson adds value Empower Meds / November 26, 2025
UncategorizedSingapore Founders Longevity Forum reveals first wave of speakers Empower Meds / November 26, 2025
Uncategorized‘The NAD+ system is under daily attack – it needs boosting’ Empower Meds / November 26, 2025
UncategorizedHCW Biologics prices $6.9 million registered direct offering – Longevity.Technology Empower Meds / November 26, 2025
UncategorizedCompany behind ‘world’s first AI doctor’s office’ closes down Empower Meds / November 26, 2025
UncategorizedFountain Life enhances early disease detection with AI-driven diagnostics – Longevity.Technology Empower Meds / November 26, 2025
